Clincial Trial Center for Functional Foods
Jeonju, Jeollabok-do, 560-822, South Korea
NCT Number: NCT01826409
This study was conducted to investigate the effects of daily supplementation of fermented red ginseng (FRG) on glycemic status in subjects with impaired fasting glucose (IFG) or type 2 diabetes.
Looking for future studies?
Notify Me20 year–75 year
All sexes
Interventional
Phase 2 / Phase 3
Jeonju, Jeollabok-do, 560-822, South Korea
This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during meal tolerance test were assessed before and after the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fermented red ginseng 2.7g/day for 4 weeks
Placebo 2.7g/day for 4 weeks
Time frame: 4 weeks
Fasting and postprandial glucose profiles during meal tolerance test were assessed before(baseline) and after the intervention
Time frame: 4 weeks
Change in lipid profiles were assessed before(baseline) and after the intervention
Chonbuk National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT06649344
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT07533539
Diabetes Mellitus, Diabetes Mellitus, Type 2
Seoul, South Korea
View Trial Details